Drug Susceptibility (TB)
"Comparison of Mycobacterium Growth Indicator Tube Method and Method of Proportion for Drug Susceptibility of Mycobacterium tuberculosis."
Published in TB and Outbreaks Week, December 28th, 1998
According to an abstract submitted by the authors to the 38th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, held March 18-21, 1998, in Santa Fe, New Mexico, "The reliability of Mycobacterium growth indicator tubes (MGIT) for testing susceptibility of Mycobacterium tuberculosis to isoniazid (INH), rifampin (RIF), streptomycin (SM) and ethambutol (EMB) was evaluated by comparing MGIT results to those obtained by the method of proportion (MOP), considered as reference method. Fifty-four strains of M. tuberculosis (30 selected for resistance) were tested. MGIT susceptibility testing was performed according to the manufacturer's recommendations:...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Conference Coverage
Internet TB Site Could Revolutionize Consulting Practices - Conference Coverage
rpoB Gene Mutations in Rifampin-Resistant TB Studied - Epidemiology
TB Common Among Pilgrims to Mecca - Genomics (TB)
Genes Encoding kDa and CFP-10 Proteins Examined - Pathogenesis
LPS Regulating Proteins Active in Host Defense Against TB - Testing (TB)
Gen-Probe Direct Test Sensitive in Detecting M. tuberculosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
